Boutique Diagnostics

Digital Health Market Access Consulting Firm

Digital Health Solutions

Sep 2021: What's new in the world of diagnostics?

Sep 2021: What's new in the world of diagnostics?

Exciting news flash from the world of (digital) diagnostics from market access, policy, product launches, start-ups and industry trends perspectives.

Pricing diagnostics with 4 methods. Which is the most powerful? - Watch the short video

Pricing diagnostics with 4 methods. Which is the most powerful? - Watch the short video

Personalised drug therapy for rheumatoid arthritis patients – lessons learnt from diagnostic development

Personalised drug therapy for rheumatoid arthritis patients – lessons learnt from diagnostic development

Diagnostic algorithms are increasingly helping to tailor therapies for patients. What are the key learnings in building a diagnostic algorithm to personalise therapy for rheumatoid arthritis patients? We talk to Zsolt Hollo, MD, Center of Biotechnology at Egis Pharmaceuticals PLC.

August 2021: What’s new in the world of diagnostics?

August 2021: What’s new in the world of diagnostics?

Exciting news flash from the world of (digital) diagnostics from market access, policy, product launches, start-ups and industry trends perspectives.

Number #1 access mistake diagnostics start-ups make. And how to avoid it?

Number #1 access mistake diagnostics start-ups make. And how to avoid it?

At Centivis we have the privilege to serve global, specialized, and start-up diagnostics developers. Depending on the size and maturity of the businesses, unique access challenges arise. We are thrilled to support start-ups / scale-ups since they are the engine of innovation in the field. What is the Nr. #1 access mistake diagnostics start-ups make. And how to avoid it?

July 2021: What’s new in the world of diagnostics?

July 2021: What’s new in the world of diagnostics?

Exciting news flash from the world of (digital) diagnostics from market access, policy, product launches, start-ups and industry trends perspectives.

June 2021: What’s new in the world of diagnostics?

June 2021: What’s new in the world of diagnostics?

Exciting news flash from the world of (digital) diagnostics from market access, policy, product launches, start-ups and industry trends perspectives.

Securing coverage for digital diagnostics | presentation for Zurich University of Applied Sciences

Securing coverage for digital diagnostics | presentation for Zurich University of Applied Sciences

Very recently Anastasios Gkiokas shared our view on “Securing coverage for digital diagnostic solutions”. Read the blog entry for the key highlights of his talk.

May 2021: What’s new in the world of diagnostics?

May 2021: What’s new in the world of diagnostics?

Exciting news flash from the world of (digital) diagnostics from market access, policy, product launches, start-ups and industry trends perspectives.

April 2021: What’s new in the world of (digital) diagnostics?

April 2021: What’s new in the world of (digital) diagnostics?

Exciting news flash from the world of (digital) diagnostics from market access, policy, product launches, start-ups and industry trends perspectives.

3 interesting reimbursement, policy learnings in oncology diagnostics (EDL, liquid biopsy, breast cancer recurrence risk scores)

3 interesting reimbursement, policy learnings in oncology diagnostics (EDL, liquid biopsy, breast cancer recurrence risk scores)

1. EGFR tests included for NSCLC in WHO’s third Essential Diagnostics List

2. Germany has a liquid biopsy tariff for locally advanced or metastatic NSCLC

3. Breast cancer recurrence risk scores: Oncotype DX first to be nationally reimbursed in Germany but others may soon join the game